Dr. Afshinnia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
901 LAKESHORE DR
STE 208
Ishpeming, MI 49849
Summary
- Dr. Farsad Afshinnia is a nephrologist based in Ann Arbor, MI. He completed his fellowship in nephrology at the University of Michigan and his residency in internal medicine at the Brookdale University Hospital and Medical Center. He graduated from Isfahan University of Medical Sciences. His research work includes publications on lupus nephritis, diabetic kidney disease, and chronic kidney disease, appearing in journals such as Kidney International Reports, Diabetes Care, Journal of American Society of Nephrology. Dr. Afshinnia has been recognized with a CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR.
Education & Training
- University of MichiganFellowship, Nephrology, 2010 - 2012
- One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2002 - 2005
- Isfahan University of Medical SciencesClass of 1999
Certifications & Licensure
- CA State Medical License 2005 - 2025
- MI State Medical License 2009 - 2025
- MN State Medical License 2007 - 2025
- WA State Medical License 2024 - 2025
- NJ State Medical License 2005 - 2007
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Voclosporin Induces Systemic Lipidomic Alterations: Implications for Lupus Nephritis Remission.Farsad Afshinnia, Thekkelnaycke M Rajendiran, Jaeman Byun, Manikanta Swamy Arnipalli, Linda M Rehaume
Kidney International Reports. 2024-08-01 - 1 citationsTubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease.Anna V Mathew, Pradeep Kayampilly, Jaeman Byun, Viji Nair, Farsad Afshinnia
American Journal of Physiology. Renal Physiology. 2024-01-01 - 4 citationsLow concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients.Baohai Shao, Farsad Afshinnia, Anna V Mathew, Graziella E Ronsein, Carissa Thornock
Journal of Lipid Research. 2023-06-01
Press Mentions
- Precision Medicine Helps Identify "At-Risk Rapid Decliners" in Early-Stage Kidney DiseaseJuly 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: